BHI Therapeutic Sciences attended the World Economic Forum in Davos, Switzerland.
The 2018 World Economic Forum (WEF) in Davos explored the ideas, innovations and discoveries that are reshaping our world by working closely with those in the vanguard of change from such fields as the arts, culture, engineering, media, medicine, science, and technology. During the past few days, the US-based company BHI Therapeutic Sciences (BHITS) represented by Brian Mehling, MD, Founder and Chief Medical Officer; Klara Doert, President of International Business Development; Katarina Novakova, Director of Relations; and Manuel McDonald,...
read moreWORLD-RENOWNED STEM CELL RESEARCHER AND BOARD-CERTIFIED SURGEON, DR. BRIAN MEHLING, SET TO ATTEND THE 48TH ANNUAL WORLD ECONOMIC FORUM IN DAVOS
FOUNDER OF BLUE HORIZON INTERNATIONAL AVAILABLE TO DISCUSS BREAKTHROUGHS IN STEM CELL RESEARCH ZURICH, Switzerland – January 18, 2017 – Dr. Brian Mehling, world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending The 48th Annual World Economic Forum (WEF) in DAVOS from January 23-26. This will be Dr. Mehling’s sixth year attending the global conference. The theme of this year’s forum is “Creating a Shared Future in a Fractured...
read moreBrian Mehling, M.D. and Blue Horizon International team to attend 3 Day Masterclass in Clinical Trials in New York
The 3 day long Masterclass in Clinical Trials and Medicine Development is organized by Terrapinn Ltd and will be held during February 22 – 24, 2017 in New York, NY. The Masterclass in Clinical Trials is designed to provide insight into new business opportunities in the field of clinical trials and the development process of new healthcare interventions. The course will provide insight into complex cross-disciplinary integrated health within the process of diffusion of new medical interventions, from pharmaceuticals, medical...
read moreBlue Horizon International making a splash at film festivals worldwide
Brian Mehling, M.D. and Blue Horizon International (BHI) have recently been making headlines – from being featured in VOGUE magazine, news of the preview screening of their stem cell documentary “Stem Cells – The Next Frontier,” which was screened during the Tribeca Film Festival in April, to its screening at the Cannes Film Festival on May 25th. There was also a well-attended networking event that followed the next day to celebrate the successful screening in Cannes. “Stem Cells – The Next Frontier” is a documentary about stem...
read moreBlue Horizon International team to attend Clinical Trials Masterclass in New York
Blue Horizon International team to attend Clinical Trials Masterclass in New York Brian Mehling, M.D. and Marina Manvelyan, Ph.D., will attend a three-day long Masterclass in Clinical Trials and Medicine Development from February 22 – 24, 2017 in New York, NY. The Masterclass in Clinical Trials is designed to provide insight into new business opportunities in the field of clinical trials and the development process of new healthcare interventions. The course will provide insight into complex cross-disciplinary integrated...
read moreStem Cell Documentary by Brian Mehling, M.D.‘s company Industrial Motion Pictures screening at Sundance Film Festival.
The documentary “Stem Cells: The Next Frontier” is set to be screened on Tuesday, January 24, 2017 at 7pm at the Sunrise Lodge in Park City, Utah. Stem cell research is the next frontier in medicine, but many have only the narrowest understanding of what it is, what it can do, and why it isn’t explored to its full potential in the United States. The creators of the 20 minute short movie joined forces with Blue Horizon International, BHI Therapeutic Sciences and Blue Horizon Charitable Foundation teams, to explore what exactly stem...
read moreBrian Mehling, M.D., to attend World Economic Forum in Davos.
Brian Mehling, M.D., US orthopedic trauma surgeon, stem cell researcher and founder of Blue Horizon International to attend World Economic Forum in Davos. Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending the 47th Annual World Economic Forum (WEF) in Davos from January 17-20, 2017. This will be Dr. Mehling’s fifth year attending the global conference. The theme of this year’s forum is Responsive and Responsible...
read moreBlue Horizon International exhibits at World Congress on Anti-Aging Medicine in Las Vegas
Blue Horizon International(BHI), Alpha Blu Skin Care, BHI Therapeutic Sciences, and BHI Rejuvenation participated in the 24th World Congress on Anti-Aging Medicine & Exhibition in Las Vegas, December 9-11, 2016. BHI’s skin care line, Alpha Blu Skin Care was available for purchase. The four-piece kit contains a special skin serum, day cream, night cream and an eye cream. The serum was recently featured in a Dermascope magazine contest as a contender for its award for best serum. The kit is available for purchase on Amazon or at...
read moreBrian Mehling, M.D. presents at International Conference and Expo on Musculoskeletal Disease and Regeneration in Chicago
American orthopedic surgeon and internationally recognized stem cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo on Musculoskeletal Disease and Regeneration. The conference was held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy for arthritis and joint injuries. “Stem cell treatments are, without a doubt, the future of medicine and we believe their...
read moreSpring 2014 Fundraiser & Networking Event
RSVP: [email protected] INFO: elevatenewyork.org
read more
